AVEO Execs Face Fraud Charges from SEC; Company to Pay $4 Million to Settle April 01, 2016Vol.42 No.13By Paul Goldberg
Study: Reolysin-Paclitaxel Combination Demonstrates Higher Response than Paclitaxel Therapy Alone March 31, 2016Vol.39 No.03
Atezolizumab Immunotherapy Boosts OS Compared to Docetaxel in Phase II Trial March 31, 2016Vol.39 No.03
Vyxeos Injection Improves Overall Survival in Phase III Acute Myeloid Leukemia Trial March 31, 2016Vol.39 No.03
